EDAP TMS SA — Form 8-K
Filed August 14, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 71/100
What the filing says
EDAP TMS S.A. agreed to sell 8,425,000 ADSs (representing ordinary shares) at $4.75 per ADS to underwriters TD Securities and Mizuho Securities on August 11, 2026, with an option to purchase an additional 1,263,750 ADSs at the same price. Gross proceeds approximately $40.0M before $2.4M underwriting discount ($0.285/ADS), net ~$37.6M. The company is a French medical device company with market cap ~$61.8M, making this capital raise ~65% of current market value.
Why this rating
Significant capital raise relative to company size (65% of market cap). Proceeds will strengthen balance sheet but also represent substantial dilution to existing shareholders. Material financing event for a small-cap company.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.